|

18F-OP-801 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 18F Hydroxyl Dendrimer

Pipeline

Phase 1/2: 1

Top Sponsors

  • Ashvattha Therapeutics, Inc.1

Indications

  • Alzheimer Disease (AD)1
  • Parkinson Disease (PD)1
  • Amyotrophic Lateral Sclerosis (ALS)1
  • Alzheimer's Disease1
  • Parkinson's Disease1

San Francisco, California1 trial

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

UCSF

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.